Siren raised $11.8 million in funding led by Anathem Ventures, with participation from existing investors DCM, Khosla Ventures, 500 Startups, and Founders Fund

Denmark United States Investments 27 May 2020
Share on FacebookShare on Twitter

Siren, an Aarhus, Denmark and San Francisco, USA-based medical device company, announced the completion of $11.8M in capital investment in a series B round.

The funding led by Anathem Ventures, with participation from existing investors DCM, Khosla Ventures, 500 Startups, and Peter Thiel’s Founders Fund.

In connection with the transaction, DCM Partner Jason Krikorian will join Siren’s board and Anathem Managing Partner Crystal McKellar will join Siren as an advisor.

Siren Care, founded in 2015 by Henk Jan Scholten, Jie Fu and Ran Ma (CEO), is building smart, washable fabric wearables — the first of which is a pair of socks meant to help those with diabetes monitor their foot health and detect dangerous injuries early. The products are based on Neurofabrics, a novel way to embed electronics directly inside of fabric to create smart textiles that are flexible, washable, and seamless; and can be produced on standard weaving machines.

Prior to this round, Siren raised about $10M in venture capital.